1 completed, 1 enrolling by invitation, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Enrolling by invitation 1, Recruiting 1 |
Follow Fasenra: new trials by email Literature Review of Fasenra trials Research Report on Fasenra
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fasenra: An Asthma Study Budesonide-albuterol, Benralizumab - Eosinophilic Asthma, Severe Asthma | Phase 4 | Enrolling by invitation | Endeavor Health | 40 | 2026-07-01 | 2026-09-15 |
| Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping Dupilumab, Benralizumab - Moderate to Severe Asthma | Phase 4 | Recruiting | University of California, San Diego | 120 | 2024-02-19 | 2024-08-19 |
| BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging Benralizumab - Asthma | Phase 4 | Completed | AstraZeneca | 45 | 2022-10-11 | 2025-03-25 |
Asthma (3) · Pulmonary Eosinophilia (2)
AstraZeneca (1) · Endeavor Health (1) · University of California, San Diego (1)
United States (3) · Australia (1) · Belgium (1) · France (1) · Portugal (1) · Spain (1) · United Kingdom (1)
Giselle Mosnaim, MD, MS (1) · Kelan Tantisira, MD (1)
R01HL161362 (1)